Want to create an interactive transcript for this episode?
Podcast: Pharmacy Podcast Network
Episode: Why Rare-Ultra Orphan Therapies need early Market Access planning and innovative solutions | Ascella Health
Description: Success in launching new therapies for rare diseases (RDs) implies the ability for the manufacturer to achieve a level of reimbursed price and a level of market access that are commercially viable on the market. Access to RD therapies is challenging because the legal and policy frameworks may be absent, funding may be insufficient and/or payers do not see the justification with the prices for these therapies. The industry has, however, a real opportunity to partner with healthcare stakeholders. There needs to be continued support to provide the education towards payers, drive evidence-based pricing, and innovative contracting, and address t...